GlassScriptPhysician profile
Jagdish B Bhagat
NPI 1568464485
$3,925.21
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $449 · 2021: $1,399 · 2022: $220 · 2023: $212 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $933.66 | 2019-2022 | |
| Abbvie INC. | $479.36 | 2021-2024 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $432.80 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $306.79 | 2019 | |
| Amarin Pharma, INC. | $207.42 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $158.04 | 2021 | |
| Janssen Pharmaceuticals, INC | $150.19 | 2020-2021 | |
| Dexcom, INC. | $125.52 | 2021 | |
| Urovant Sciences INC | $125.00 | 2022 | |
| Lilly USA, LLC | $106.94 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $103.68 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $101.69 | 2019-2020 | |
| Medtronic Vascular, INC. | $92.32 | 2020 | |
| Glaxosmithkline, LLC. | $92.05 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $82.66 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $63.99 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $55.63 | 2021 | |
| Sanofi-Aventis U.S. LLC | $46.37 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $43.76 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $43.62 | 2019-2020 | |
| Eisai INC. | $42.32 | 2021 | |
| Genentech USA, INC. | $24.26 | 2019 | |
| Nalu Medical, INC. | $21.25 | 2024 | Nalu Neurostimulation System |
| Nestle Healthcare Nutrition INC. | $20.63 | 2021 | |
| Sanofi Pasteur INC. | $18.72 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.72 | 2019 | |
| Ibsa Pharma INC. | $16.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagdish Bhagat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.